| Product NDC: | 33342-037 |
| Proprietary Name: | Escitalopram Oxalate |
| Non Proprietary Name: | Escitalopram Oxalate |
| Active Ingredient(s): | 10 mg/21 & nbsp; Escitalopram Oxalate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 33342-037 |
| Labeler Name: | Macleods Pharmaceuticals Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202210 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120911 |
| Package NDC: | 33342-037-11 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (33342-037-11) |
| NDC Code | 33342-037-11 |
| Proprietary Name | Escitalopram Oxalate |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (33342-037-11) |
| Product NDC | 33342-037 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Escitalopram Oxalate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120911 |
| Marketing Category Name | ANDA |
| Labeler Name | Macleods Pharmaceuticals Limited |
| Substance Name | ESCITALOPRAM OXALATE |
| Strength Number | 10 |
| Strength Unit | mg/21 |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |